Atrium Innovations Inc. (Atrium) is a Canada-based company engaged in the development, manufacturing, and commercialization of dietary supplements endorsed by health professionals. The Company owns more than 16 brands of products which are distributed mainly in the healthcare practitioner and health food and specialized store channels in more than 35 countries, with a primary focus in North America and Europe. The Company manufactures and markets more than 2,000 health and nutrition finished products. The products are generated primarily from natural sources and include vitamins, minerals and specialized products such as enzymes, probiotics and omega-3. In October 2013, the Company announced that it has acquired 70% interest of Mucos Pharma CZ s.r.o.